Senvest Partners was adding to its short portfolio a couple of months back, however both short and long positions suffered a loss in May. The fund was down 2% in last month, trimming down the year-to-date gain to 6.7%, according to a monthly letter reviewed by ValueWalk. The Canadian based, value oriented hedge fund, had a spectacular 2013 with a return of 80%. The earnings season did not prove to be a good time for the hedge fund. The fund’s largest losers on the long side were, Depomed Inc (NASDAQ:DEPO), Gain Capital Holdings Inc (NYSE:GCAP) and Senomyx Inc. (NASDAQ:SNMX). Depomed, a pharmaceutical company specializing in…
Senvest Opens New Stake In National Bank of Greece (NBG)
HFA Staff
The post above is drafted by the collaboration of the Hedge Fund Alpha Team.